Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 618

1.

Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.

Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL.

Hum Pathol. 2001 May;32(5):487-93.

PMID:
11381366
3.

Biologic markers in ductal carcinoma in situ and concurrent infiltrating carcinoma. A comparison of eight contemporary grading systems.

Leong AS, Sormunen RT, Vinyuvat S, Hamdani RW, Suthipintawong C.

Am J Clin Pathol. 2001 May;115(5):709-18.

PMID:
11345835
4.

Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.

Yang M, Moriya T, Oguma M, De La Cruz C, Endoh M, Ishida T, Hirakawa H, Orita Y, Ohuchi N, Sasano H.

Pathol Int. 2003 Jul;53(7):422-8.

PMID:
12828606
5.

Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.

Wärnberg F, Nordgren H, Bergkvist L, Holmberg L.

Br J Cancer. 2001 Sep 14;85(6):869-74.

6.

Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast.

Iwase H, Ando Y, Ichihara S, Toyoshima S, Nakamura T, Karamatsu S, Ito Y, Yamashita H, Toyama T, Omoto Y, Fujii Y, Mitsuyama S, Kobayashi S.

Breast Cancer. 2001;8(2):98-104.

PMID:
11342981
7.

[Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].

Polgár C, Orosz Z, Kahán Z, Gábor G, Jani N, Cserni G, Hadijev J, Kulka J, Sulyok Z, Boross G, Lázár G, László Z, Diczházi C, Udvarhelyi N, Szabó E, Péntek Z, Major T, Fodor J.

Magy Onkol. 2008 Sep;52(3):269-77. doi: 10.1556/MOnkol.52.2008.3.4. Hungarian.

PMID:
18845497
8.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793
9.
10.

Ductal carcinoma in situ of the breast: correlation between histologic classifications and biologic markers.

Moreno A, Lloveras B, Figueras A, Escobedo A, Ramon JM, Sierra A, Fabra A.

Mod Pathol. 1997 Nov;10(11):1088-92.

PMID:
9388058
11.

Breast carcinoma in women 35 years and younger: a pathological study.

Fernandopulle SM, Cher-Siangang P, Tan PH.

Pathology. 2006 Jun;38(3):219-22.

PMID:
16753742
12.
14.

Biological profile of in situ breast cancer investigated by immunohistochemical technique.

Albonico G, Querzoli P, Ferretti S, Rinaldi R, Nenci I.

Cancer Detect Prev. 1998;22(4):313-8.

PMID:
9674874
15.
16.

Apoptosis in ductal carcinoma in situ of the breast.

Moreno A, Figueras A, Lloveras B, Escobedo A, Griera E, Sierra A, Fabra A.

Breast J. 2001 Jul-Aug;7(4):245-8.

PMID:
11678802
19.

The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.

Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.

Cancer. 2004 Jun 1;100(11):2317-27.

20.

Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.

Altintas S, Lambein K, Huizing MT, Braems G, Asjoe FT, Hellemans H, Van Marck E, Weyler J, Praet M, Van den Broecke R, Vermorken JB, Tjalma WA.

Breast J. 2009 Mar-Apr;15(2):120-32. doi: 10.1111/j.1524-4741.2009.00686.x.

PMID:
19292797

Supplemental Content

Support Center